Acta Neuropathologica

, 116:583

Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains

Review

DOI: 10.1007/s00401-008-0449-0

Cite this article as:
Askanas, V. & Engel, W.K. Acta Neuropathol (2008) 116: 583. doi:10.1007/s00401-008-0449-0
  • 318 Downloads

Abstract

Sporadic inclusion-body myositis (s-IBM), the most common muscle disease of older persons, is of unknown cause and lacks successful treatment. Here we summarize diagnostic criteria and discuss our current understanding of the steps in the pathogenic cascade. While it is agreed that both degeneration and mononuclear-cell inflammation are components of the s-IBM pathology, how each relates to the pathogenesis remains unsettled. We suggest that the intra-muscle-fiber degenerative component plays the primary role, leading to muscle-fiber destruction and clinical weakness, since anti-inflammatory treatments are not of sustained benefit. We discuss possible treatment strategies aimed toward ameliorating a degenerative component, for example, lithium and resveratrol. Also discussed are the intriguing phenotypic similarities between s-IBM muscle fibers and the brains of Alzheimer and Parkinson’s diseases, the most common neurodegenerative diseases associated with aging. Similarities include, in the respective tissues, cellular aging, mitochondrial abnormalities, oxidative and endoplasmic-reticulum stresses, proteasome inhibition and multiprotein aggregates.

Keywords

Inclusion-body myositisAmyloid-betaMultiprotein aggregatesMuscle-fiber degenerationInflammationEndoplasmic-reticulum stressAlzheimer’s diseaseParkinson’s diseaseLithiumResveratrolAging

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.Department of Neurology, USC Neuromuscular CenterGood Samaritan Hospital, University of Southern California Keck School of MedicineLos AngelesUSA